The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. Elsevier’s Current Opinion journals comprise of 26 leading titles in life sciences and adjacent fields.

Current Opinion in Chemical Biology

IMPACT FACTOR: 7.889
5-Year Impact Factor: 7.210
Issues per year: 6 issues
Editorial Board

Current Opinion in Chemical Biology

The Current Opinion journals were developed out of the recognition that it is increasingly difficult for specialists to keep up to date with the expanding volume of information published in their subject. In Current Opinion in Chemical Biology, we help the reader by providing in a systematic manner:
1. The views of experts on current advances in chemical biology in a clear and readable form.
2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications.

Division of the subject into sections:
The subject of chemical biology is divided into themed sections which are reviewed regularly to keep them relevant. For 2015 they are:

  • Omics
  • Bioinorganic chemistry
  • Biocatalysis and Biotransformation
  • Next Generation Therapeutics
  • Molecular Imaging
  • Synthetic Biology
  • Synthetic Biomolecules
  • Energy
  • Mechanistic Biology

Selection of topics to be reviewed:
Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.

Reviews:
Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.

Editorial Overview:
Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.
This successful format has made Current Opinion in Chemical Biology one of the most highly regarded and highly cited review journals in the field.

Ethics in Publishing: General Statement
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.

For more information, please refer to: http://www.elsevier.com/conflictsofinterest

Best Cited over the last year.

Subscribe to RSS Sciverse Scopus

Metal-based anticancer chemotherapeutic agents

Volume 19, Issue 1, 01 January 2014, Pp 144-153
Nafees Muhammad | Zijian Guo

Hydrothermal conversion of biomass to fuels and energetic materials

Volume 17, Issue 3, 01 June 2013, Pp 515-521
Andrea Kruse | Axel Funke | Maria Magdalena Titirici

Targeted delivery of platinum-based anticancer complexes

Volume 17, Issue 2, 01 April 2013, Pp 175-188
Jennifer S. Butler | Peter J. Sadler

Transcriptomics in the RNA-seq era

Volume 17, Issue 1, 01 February 2013, Pp 4-11
Paul A. McGettigan

Exploring bacterial lignin degradation

Volume 19, Issue 1, 01 April 2014, Pp 1-7
Margaret E. Brown | Michelle C Y Chang

Protein conjugation with genetically encoded unnatural amino acids

Volume 17, Issue 3, 01 June 2013, Pp 412-419
Chan Hyuk Kim | Jun Y. Axup | Peter G. Schultz

Recent achievements in developing the biocatalytic toolbox for chiral amine synthesis

Volume 19, Issue 1, 01 January 2014, Pp 180-192
Hannes Kohls | Fabian Steffen-Munsberg | Matthias Höhne

On the development of new biocatalytic processes for practical pharmaceutical synthesis

Volume 17, Issue 2, 01 April 2013, Pp 284-292
Gjalt W. Huisman | Steven J. Collier

Strategies for the discovery and engineering of enzymes for biocatalysis

Volume 17, Issue 2, 01 April 2013, Pp 215-220
Timo Davids | Marlen Schmidt | Dominique Böttcher | Uwe T. Bornscheuer

De novo enzymes by computational design

Volume 17, Issue 2, 01 April 2013, Pp 221-228
Hajo Kries | Rebecca Blomberg | Donald Hilvert

Targeting T cells to tumor cells using bispecific antibodies

Volume 17, Issue 3, 01 June 2013, Pp 385-392
Stanley R. Frankel | Patrick A. Baeuerle

15 years of zebrafish chemical screening

Volume 24, Issue , 01 February 2015, Pp 58-70
Andrew J. Rennekamp | Randall T. Peterson

Trans-Cyclooctene-a stable, voracious dienophile for bioorthogonal labeling

Volume 17, Issue 5, 01 October 2013, Pp 753-760
Ramajeyam Selvaraj | Joseph M. Fox

Advanced biofuel production by the yeast saccharomyces cerevisiae

Volume 17, Issue 3, 01 June 2013, Pp 480-488
Nicolaas A. Buijs | Verena Siewers | Jens Nielsen

Advances in microalgae engineering and synthetic biology applications for biofuel production

Volume 17, Issue 3, 01 June 2013, Pp 489-495
Javier A. Gimpel | Elizabeth A. Specht | D. Ryan Georgianna | Stephen P. Mayfield

Druggable protein-protein interactions - from hot spots to hot segments

Volume 17, Issue 6, 01 December 2013, Pp 952-959
Nir London | Barak Raveh | Ora Schueler-Furman

Next generation biofuel engineering in prokaryotes

Volume 17, Issue 3, 01 June 2013, Pp 462-471
Luisa S. Gronenberg | Ryan J. Marcheschi | James C. Liao

New enzyme insights drive advances in commercial ethanol production

Volume 19, Issue 1, 01 January 2014, Pp 162-170
Paul V. Harris | Feng Xu | Nathaniel E. Kreel | Connie Kang | Shiro Fukuyama

Improving and repurposing biocatalysts via directed evolution

Volume 25, Issue , 01 April 2015, Pp 55-64
Carl A. Denard | Hengqian Ren | Huimin Zhao

Target deconvolution techniques in modern phenotypic profiling

Volume 17, Issue 1, 01 February 2013, Pp 118-126
Jiyoun Lee | Matthew Bogyo

Enzyme catalysed tandem reactions

Volume 17, Issue 2, 01 April 2013, Pp 236-249
Isabel Oroz-Guinea | Eduardo García-Junceda

Recent achievments in the design and engineering of artificial metalloenzymes

Volume 19, Issue 1, 01 January 2014, Pp 99-106
Marc Dürrenberger | Thomas R. Ward

Computational tools for designing and engineering enzymes

Volume 19, Issue 1, 01 April 2014, Pp 8-16
Jiri Damborsky | Jan Brezovsky

Artificial metalloenzymes for enantioselective catalysis

Volume 19, Issue 1, 01 January 2014, Pp 135-143
Jeffrey Bos | Gerard Roelfes

Lignocellulose degradation mechanisms across the Tree of Life

Volume 29, Issue , 01 December 2015, Pp 108-119
Simon M. Cragg | Gregg T. Beckham | Neil C. Bruce | Timothy D.H. Bugg | Daniel L. Distel | Paul Dupree | Amaia Green Etxabe | Barry S. Goodell | Jody Jellison | John E. McGeehan | Simon J. McQueen-Mason | Kirk Schnorr | Paul H. Walton | Joy E.M. Watts | Martin Zimmer